Ball & Co Wealth Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,066
Closed -$24K – 59
2026
Q2
$24K Hold
3,066
– – 0.02% 48
2026
Q1
$19K Hold
3,066
– – 0.02% 54
2025
Q4
$18K Hold
3,066
– – 0.01% 52
2025
Q3
$16K Sell
3,066
-440
-13% -$1.87K 0.01% 60
2025
Q2
$12K Hold
3,506
– – 0.01% 49
2025
Q1
$10K Hold
3,506
– – 0.01% 46
2024
Q4
$10K Buy
+3,506
New +$10.2K 0.01% 48

Other funds holding PBYI

Ball & Co Wealth Management's PBYI Position: Q3 2026 in Review

Ball & Co Wealth Management sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 3,066 shares — an estimated $24K sold.

Ball & Co Wealth Management first reported a position in PBYI in Q4 2024 and held it in 7 quarters. The position peaked at $24K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Ball & Co Wealth Management reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
  • Ball & Co Wealth Management sold 3,066 Puma Biotechnology shares in Q3 2026, an estimated $24K.
  • Ball & Co Wealth Management first reported a position in Puma Biotechnology in Q4 2024 and held it in 7 quarters.
  • Ball & Co Wealth Management's Puma Biotechnology position peaked at $24K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Ball & Co Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.